AG-490 (Tyrphostin B42): Precision JAK2/EGFR Inhibition for Cancer and Immunopathology Research

Executive Summary: AG-490 (Tyrphostin B42) is a high-purity tyrosine kinase inhibitor with IC₅₀ values of approximately 10 μM (JAK2), 0.1 μM (EGFR), and 13.5 μM (ErbB2) under in vitro conditions (APExBIO). It blocks JAK2-dependent signaling, suppressing STAT activation in cancer and immune cells (Zhang et al., 2025). AG-490 is insoluble in water but dissolves in DMSO (≥14.7 mg/mL) and ethanol (≥4.73 mg/mL with warming/ultrasound). It is used extensively for research into tumor microenvironment modulation, immunopathological state suppression, and cytokine-induced T cell proliferation. The compound is supplied by APExBIO with >99.5% purity for research only (APExBIO).

Biological Rationale

Tyrosine kinases such as JAK2, EGFR, and ErbB2 control essential cellular processes, including proliferation, survival, and immune response. Dysregulation of these kinases is implicated in oncogenesis, immune evasion, and chronic inflammation (Zhang et al., 2025). The JAK2/STAT6 axis is critical for M2 macrophage polarization, which promotes tumor growth and immune suppression in hepatocellular carcinoma (HCC) and other cancers. Aberrant activation of JAK2-STAT and MAPK pathways is a hallmark of various hematological and solid tumors. Targeted kinase inhibition enables researchers to dissect these pathways and their contributions to disease phenotypes (see prior analysis).

Mechanism of Action of AG-490 (Tyrphostin B42)

AG-490 (Tyrphostin B42) is a synthetic small molecule of the tyrphostin class. It competitively inhibits the ATP-binding site of JAK2, EGFR, and ErbB2 tyrosine kinases. This inhibition prevents phosphorylation of downstream signal transducers and activators of transcription (STAT1, STAT3, STAT5a, STAT5b), and disrupts MAPK pathway activation. In immune cells, AG-490 blocks cytokine-induced JAK2 activation, suppressing STAT3 and STAT5 phosphorylation. In T cell lines, it inhibits IL-2-driven proliferation and DNA binding activity of STAT proteins. In cancer models, AG-490 interrupts oncogenic signaling, impairing tumor cell growth and modulating the tumor immune microenvironment (Zhang et al., 2025). The compound is highly selective for tyrosine kinases and does not directly inhibit serine/threonine kinases under standard assay conditions.

Evidence & Benchmarks

• AG-490 inhibits JAK2 kinase activity with an IC₅₀ of approximately 10 μM in cell-free enzymatic assays (APExBIO).
• EGFR inhibition by AG-490 occurs at an IC₅₀ of 0.1 μM under in vitro conditions (APExBIO).
• AG-490 blocks cytokine-induced JAK2 activation in eosinophils and reduces STAT3 phosphorylation in T cells (Zhang et al., 2025).
• In IL-2-dependent T cell lines, AG-490 suppresses proliferation and STAT5a/b phosphorylation at 5–20 μM, reducing DNA binding activity of STAT1, STAT3, STAT5a, and STAT5b after 3–6 hours incubation (Zhang et al., 2025).
• AG-490 inhibits M2 macrophage polarization by blocking JAK2/STAT6 signaling in THP-1 macrophages exposed to SNORD52-positive exosomes (Zhang et al., 2025).
• It does not inhibit serine/threonine kinases such as PKC or PKA at concentrations up to 50 μM (see AG-490: Unraveling JAK2/STAT6 Inhibition for details).
• AG-490 is insoluble in water; its solubility in DMSO is ≥14.7 mg/mL and in ethanol is ≥4.73 mg/mL (APExBIO).
• The product is supplied as a >99.5% pure solid, stored at -20°C, and solutions are not recommended for long-term storage (APExBIO).

Prior reviews have summarized AG-490’s role in macrophage polarization; this article quantifies IC₅₀ values and clarifies selectivity under defined conditions.

Applications, Limits & Misconceptions

Applications:

• Dissection of JAK2/STAT, EGFR, and MAPK pathways in cancer and immune cells.
• Modulation of macrophage polarization in tumor microenvironment models (Zhang et al., 2025).
• Suppression of IL-2-induced T cell proliferation and downstream signaling events.
• Benchmarking kinase selectivity in vitro using defined IC₅₀ values.
• Tool compound for high-impact signal transduction research (see previous analysis).

Limits:

• Not suitable for in vivo therapeutic use (research only).
• Insoluble in water; requires DMSO or ethanol for solution preparation.
• May not distinguish between JAK2 and JAK3 at high concentrations.
• Does not inhibit non-tyrosine kinases (e.g., serine/threonine kinases) at tested doses.
• Long-term solution stability is poor; fresh preparation recommended.

Common Pitfalls or Misconceptions

• AG-490 is not a pan-kinase inhibitor; it is selective for JAK2, EGFR, and ErbB2.
• It does not function as a direct immunosuppressant in vivo; its effects are pathway-specific and require defined experimental context.
• AG-490 is not recommended for clinical or diagnostic use (for research only).
• Do not store AG-490 solutions for extended periods; hydrolysis and degradation reduce activity.
• IC₅₀ values are context-dependent; verify assay conditions before direct comparison.

Workflow Integration & Parameters

For signal transduction studies, dissolve AG-490 in DMSO (≥14.7 mg/mL) or ethanol (≥4.73 mg/mL, with gentle warming and ultrasound). Prepare fresh stock solutions and store at -20°C; avoid repeated freeze-thaw cycles. Typical working concentrations range from 1–20 μM in cell-based assays. Ensure final DMSO or ethanol concentrations do not exceed cytotoxic thresholds for your cell type. For kinase assays, verify buffer composition, ATP concentration, and incubation time. AG-490 (A4139) is available from APExBIO (AG-490 product page), supplied at >99.5% purity. Refer to prior mechanistic analyses for comparative protocols and specificity benchmarking; this article extends the discussion with updated quantitative data and workflow guidance.

Conclusion & Outlook

AG-490 (Tyrphostin B42) is a validated, high-purity research tool for dissecting JAK2, EGFR, and ErbB2 signaling in cancer and immunological models. It enables precise modulation of the JAK-STAT and MAPK pathways, supporting studies on tumor immunity, macrophage polarization, and cytokine signaling. Its quantitative benchmarks, selectivity profile, and solubility parameters make it indispensable for advanced signal transduction research. Researchers should follow recommended handling practices and assay conditions to maximize reproducibility and interpretability. For up-to-date specifications and ordering, consult APExBIO’s AG-490 (A4139) page.